Skip to content

Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers

the Effectiveness of Echinacea, Propolis and Vitamin C in the Prevention of Respiratory Tract Infections and Gastroenteritis in Preschool Age Children: a Prospective Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00231218
Enrollment
104
Registered
2005-10-04
Start date
2006-01-31
Completion date
2006-03-31
Last updated
2006-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Cold, Gastroenteritis

Keywords

vitamin c, echinacea, propolis, upper respiratory tract infection, common cold, gastroenteritis, dietary supplement, herbal remedy

Brief summary

We hypothesize the herbal preparation will enhance the preschoolers' immune response and when taken prophylactically for 12 weeks will decrease episodes of upper respiratory infections and gastroenteritis in the active versus the control group.

Detailed description

This combination of herbs has been studied only once before in preschoolers. In a study of 430 preschoolers reported in Archives of Pediatric and Adolescent Medicine in March of 2004, a similar preparation with a slightly lower dose of Vitamin C decreased upper respiratory infections by 55% (308 to 138). We are repeating this study to see if our results confirm or contradict those of the previous study.

Interventions

DRUGdietary supplement--echinacea, propolis, and vitamin c

Sponsors

The Cleveland Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
3 Years to 6 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 3-6

Exclusion criteria

* Cystic fibrosis * Immunodeficiency * Bronchopulmonary dysplasia * Anatomic abnormalities of respiratory tract * Intestinal malabsorption * Allergy to sunflower seeds

Design outcomes

Primary

MeasureTime frame
upper respiratory tract infections

Secondary

MeasureTime frame
gastroenteritis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026